American Century Companies’s Heron Therapeutics HRTX Stock Holding History

American Century Companies’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-329,774	Closed	-$3.52M	–	2340
2021 Q3	$3.52M	Buy	329,774 +111	+0%	+$1.35K	﹤0.01%	1115
2021 Q2	$5.12M	Buy	329,663 +14,670	+5%	+$233K	﹤0.01%	982
2021 Q1	$5.11M	Sell	314,993 -14,256	-4%	-$254K	﹤0.01%	932
2020 Q4	$6.97M	Sell	329,249 -10,136	-3%	-$176K	0.01%	826
2020 Q3	$5.03M	Sell	339,385 -36,182	-10%	-$565K	﹤0.01%	804
2020 Q2	$5.53M	Buy	375,567 +113,223	+43%	+$1.86M	0.01%	765
2020 Q1	$3.08M	Buy	262,344 +9,950	+4%	+$187K	﹤0.01%	791
2019 Q4	$5.93M	Buy	252,394 +88,339	+54%	+$1.95M	0.01%	783
2019 Q3	$3.04M	Buy	164,055 +10,118	+7%	+$186K	﹤0.01%	898
2019 Q2	$2.86M	Buy	153,937 +23,112	+18%	+$462K	﹤0.01%	961
2019 Q1	$3.2M	Sell	130,825 -3,701	-3%	-$96.9K	﹤0.01%	918
2018 Q4	$3.49M	Buy	134,526 +2,278	+2%	+$62.6K	﹤0.01%	881
2018 Q3	$4.19M	Buy	132,248 +4,296	+3%	+$160K	﹤0.01%	899
2018 Q2	$4.97M	Buy	+127,952	New	+$4.07M	0.01%	850
2016 Q3	–	Sell	-33,598	Closed	-$606K	–	1370
2016 Q2	$606K	Sell	33,598 -7,811	-19%	-$152K	﹤0.01%	1218
2016 Q1	$786K	Buy	+41,409	New	+$817K	﹤0.01%	1151

Other funds holding HRTX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

American Century Companies's HRTX Position: Q4 2021 in Review

American Century Companies sold out of Heron Therapeutics (HRTX) in Q4 2021, closing a stake of 329,774 shares — an estimated $3.52M sold.

American Century Companies first reported a position in HRTX in Q1 2016 and held it in 16 quarters. The position peaked at $6.97M in Q4 2020. 200 funds tracked by Wall St. Rank hold HRTX as of Q4 2021.

American Century Companies reported no remaining Heron Therapeutics position as of Q4 2021 after selling out during the quarter.
American Century Companies sold 329,774 Heron Therapeutics shares in Q4 2021, an estimated $3.52M.
American Century Companies first reported a position in Heron Therapeutics in Q1 2016 and held it in 16 quarters.
American Century Companies's Heron Therapeutics position peaked at $6.97M in Q4 2020.
200 funds tracked by Wall St. Rank held Heron Therapeutics as of Q4 2021.

Based on American Century Companies's 13F filing for Q4 2021, filed 7 Feb 2022.